Status:
NOT_YET_RECRUITING
The Impact of Comprehensive Post Hospital Management Based on DHI on Cardiac Function in Patients With HF
Lead Sponsor:
Harbin Medical University
Conditions:
Heart Failure
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Due to the complex nature of HF patients' conditions, long-term treatment and management are required, especially post hospital management, which is of great significance for improving patients' cardi...
Eligibility Criteria
Inclusion
- Patients hospitalized for HF, NYHA classification II-IV upon admission
- The patient's residence is within the urban area of each center, and ReDS™ technology can be performed at home or at the outpatient clinic
- No difficulty using smartphones, with basic Chinese reading and writing skills
- Accept the terms and conditions of the study and obtain informed consent from the subjects/their families
Exclusion
- Age\<21 years old
- Patients with height\<155 cm or\>190 cm, BMI\<22 kg/m2 or\>36 kg/m2, chest circumference\<80 cm or\>115 cm, and flail chest or rib fractures
- History of pulmonary embolism
- chronic renal failure（Scr \> 443umol/L）
- History of heart transplantation or pacemaker implantation
- Severe pulmonary hypertension
- Suffering from end-stage chronic obstructive pulmonary disease, requiring home oxygen therapy
- Massive pleural effusion
- The subject is unable to complete the 6-minute walking test
- Expected lifespan\<6 months
- Researchers believe that participants are not suitable to participate in this trial (such as pregnancy, severe visual or hearing impairment, etc.)
- Individuals who are unable to understand and/or comply with this research procedure (such as those who are addicted to alcohol, substance abuse, or have mental illnesses)
- Currently participating in clinical trials of other devices or drugs
- Researchers involved in the design and execution of this study
Key Trial Info
Start Date :
May 6 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT06947148
Start Date
May 6 2025
End Date
December 31 2026
Last Update
April 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Second Affiliated Hospital of Harbin Medical University
Harbin, Heilongjiang, China, 150000